Orbis Medicines Competitors and Similar CompaniesClear all

STADA's competitors and similar companies include Faes Farma, Apeloa Pharmaceutical and Digi-Prex.

	STADA STADA Arzneimittel is a company engaged in the healthcare and pharmaceuticals business.	Faes Farma Faes Farma is a pharmaceutical company that develops, produces and commercializes pharmaceutical products and raw materials.	Apeloa Pharmaceutical Apeloa Pharmaceutical (普洛药业股份有限公司) is a company that develops and produces pharmaceutical products.	Digi-Prex Digi-Prex is a chronic disease management platform that provides a holistic solution to assist in the care of patients with chronic diseases.
Founding Date	Founding Date 1895	Founding Date 1933	Founding Date 1989	Founding Date 2019
Type	Type Public	Type Public	Type Public	Type Private
Tags	Tags Healthcare drug development healthtech pharma	Tags Healthcare drug development healthtech pharma	Tags Healthcare drug development healthtech pharma	Tags Healthcare Technology drug development healthtech pharma platform
Locations	Locations Bad Vilbel, DE HQ Beijing, CN Hangzhou Shi, CN Shanghai, CN Bad Vilbel, DE Budapest, HU Vilnius, LT see more	Locations Leioa, ES HQ Madrid, ES Atlanta, US	Locations CN HQ	Locations HQ
Employees	Employees 12,33911% increase	Employees 1,775	Employees 7,060	Employees 27
Valuation ($)	Valuation ($) 6 b	Valuation ($) 1.2 b	Valuation ($) 2.7 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) €3b (FY, 2020)	Revenue (est.) €493.6m (FY, 2024)	Revenue (est.) ¥9.7b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods €1.3b (FY, 2020)	Cost of goods €167.1m (FY, 2024)	Cost of goods ¥7.2b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit €1.7b (FY, 2020)	Gross profit €342.9m (FY, 2024)	Gross profit ¥2.5b (FY, 2025)	Gross profit N/A
Net income	Net income €181.9m (FY, 2020)	Net income €111.1m (FY, 2024)	Net income ¥890.7m (FY, 2025)	Net income N/A